Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "kidney disease: improving global outcomes" (KDIGO) controversies conference, Kidney Int, vol.91, pp.539-51, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01793663
Adrenocortical carcinoma, Endocr Rev, vol.35, pp.282-326, 2014. ,
Limited prognostic value of the 2004 international union against cancer staging classification for adrenocortical carcinoma, Cancer, vol.115, pp.243-50, 2009. ,
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options, Expert Rev Anticancer Ther, vol.2018, pp.1-9 ,
European society of endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European network for the study of adrenal tumors, Eur J Endocrinol, 2018. ,
Cancer-associated thrombotic microangiopathy, Ecancermedicalscience, vol.10, p.649, 2016. ,
Cancer-related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases, Medicine (Baltimore), vol.91, pp.195-205, 2012. ,
Malignant pheochromocytoma accompanied by microangiopathic hemolytic anemia: a case report, Jpn J Clin Oncol, vol.24, pp.171-175, 1994. ,
Diagnostic challenges associated with a complex case of cystic phaeochromocytoma presenting with malignant hypertension, microangiopathic haemolysis and acute renal failure, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc, vol.20, p.1014, 2005. ,
Phaeochromocytoma and thrombotic microangiopathy: favourable outcome despite advanced renal failure, J Clin Pathol, vol.63, pp.754-760, 2010. ,